
Nephrologist

No OPD information available
Kidney Transplant
Malignant Hypertension
ABO Incompatibility
Acute Kidney Failure
Acute Tubular Necrosis
Anemia
Asymptomatic Bacteriuria
Blood Clots
Chronic Kidney Disease
Cytomegalic Inclusion Disease
Cytomegalovirus Infection
D-Minus Hemolytic Uremic Syndrome
D-Plus Hemolytic Uremic Syndrome
End-Stage Renal Disease (ESRD)
Hemolytic Anemia
Hemolytic-Uremic Syndrome
Hepatitis
Hepatitis B
Interstitial Nephritis
Pancreas Transplant
Parathyroidectomy
Purpura
Splenectomy
Thrombocytopenia
Urinary Tract Infection (UTI)
Peter D. Hughes is a male medical professional who helps patients with various health issues related to the kidneys and other conditions. He is skilled in treating kidney transplant, malignant hypertension, acute kidney failure, anemia, blood clots, and many other health problems. Peter D. Hughes is known for his expertise in managing different kidney diseases and related complications.
Peter D. Hughes communicates with patients in a caring and understanding manner, which makes patients trust him. He listens to their concerns, explains things clearly, and involves them in making decisions about their treatment. Patients appreciate his compassionate approach and the way he puts them at ease during medical appointments.
To stay updated with the latest medical knowledge and research, Peter D. Hughes regularly attends conferences, reads medical journals, and participates in continuing education programs. This helps him provide the best possible care to his patients and stay informed about new treatments and technologies in the field of nephrology.
Peter D. Hughes collaborates closely with colleagues and other medical professionals to ensure that patients receive comprehensive and coordinated care. He values teamwork and believes that working together with other healthcare providers leads to better outcomes for patients.
Through his work, Peter D. Hughes has made a positive impact on many patients' lives by improving their health and quality of life. His dedication to providing excellent care and his commitment to ongoing learning and research have resulted in better outcomes for his patients.
One of Peter D. Hughes's notable publications is "The role of epithelial cell injury in kidney transplant outcomes - a cross-sectional study," published in JCI insight in April 15, 2025. He has also been involved in clinical trials, such as the Phase 3 trial evaluating the safety and efficacy of Clazakizumab for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
Overall, Peter D. Hughes is a highly skilled and compassionate medical professional who is dedicated to helping patients with kidney-related conditions and improving their health outcomes through his expertise and commitment to excellence in patient care.
Enrollment Status: Terminated
Published: April 24, 2024
Intervention Type: Drug, Biological
Study Drug:
Study Phase: Phase 3
